News
-
Fast Track Validation Programme 2026 – Webinar Recording available
EP PerMed organised a webinar to go through the EP PerMed Fast Track Call 2026 and answer any question about the call, the application process on 20 January 2026. The slides and recording are now available.
-
EP PerMed JTC2025 Results: Funding provided for 22 transnational Projects on Personalised Medicine
EP PerMed will fund 22 new research projects with around €34.4 million under its Joint Transnational Call 2025 “Pharmacogenomic Strategies for Personalised Medicine Approaches (PGxPM2025)”. The 22 projects will involve more than 140 research groups from 24 countries and European regions.
-
EP PerMed in-situ Visit at the Center for Precision Medicine in Brno – Report available
EP PerMed organised an in-suto visit to the Center for Precision Medicine of the University Brno (Czech Republic) on 27 and 28 November 2025, back-to-back with the first joint ICPerMed and EP PerMed Conference in Prague. The report on the visit is now available.
-
Tender Announcement: Call for Tender on Surveys 2026 – Assessment and Analysis of Genetic Testing
EP PerMed launches its first Call for Tender on Surveys and invites suitable stakeholders to apply. The topic of the tender is the assessment and analysis of genetic testing related to personalised medicine approaches for different countries and health systems.
EP PerMed JTC2026
Personalised Medicine for CARdiovascular, MEtabolic, and kidNey diseases (CARMEN2026)
EP PerMed will fund research projects in human health on innovative personalised medicine strategies for patients with cardiovascular, metabolic or kidney diseases. Research projects may focus on a single disease or explore these conditions in combination. The available budget for this call is 38 Mio. € (approx.). Deadline for pre-proposal submission in 10 February 2026.
Citizen Awareness of Personalised Medicine
Your opinion matters!
Have you been involved in a personalised treatment or are you aware of personalised medicine approaches?
EP PerMed likes to understand how well people are informed about personalised medicine, how they perceive it, and their thoughts on its potential benefits and challenges.
The anonymous survey contains 36 questions and takes approximately 10-15 minutes to complete. It is currently available in: English, Czech, Danish, Finnish, French, German, Greek, Italian, Norwegian, Dutch, Polish, Portuguese, Romanian, Spanish, Swedish and Turkish.
Mission & Objectives
EP PerMed Podcast ‘The Science of You’
The second season of the EP PerMed podcast tells four powerful stories of patients and former patients who have benefited from personalised medicine. With topics ranging from oncology and rare genetic disorders to preventive surgery and cardiovascular diseases, this season illustrates real human experiences, showing how tailored therapies are transforming the treatment process into a more effective and informed one.